The DOI matches its Crossref record; 65 of the 68 references it cites were found in a registry or an index.
Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients
Open accessAbstract
The adaptive immune response of ovarian cancer patients has been linked to survival, and is known to be impaired in the tumor microenvironment. Little is known about relationships between biobehavioral factors such as depressed mood and anxiety and the adaptive immune response in ovarian cancer. Thirty-seven patients with epithelial ovarian cancer and 14 patients with benign ovarian neoplasms completed psychosocial questionnaires pre-surgery. Lymphocytes from peripheral blood, tumor, and ascites (fluid around the tumor), were obtained on the day of surgery. Expression of the Type-1 cytokine interferon-gamma (IFN gamma), and the Type-2 cytokine interleukin-4 (IL-4) by T-helper (CD4(+)) and T-cytotoxic (CD8(+)) cells was measured under autologous tumor-stimulated, polyclonally-stimulated, or unstimulated conditions. Links with mood were examined. Among cancer patients, marked elevations in unstimulated and tumor-stimulated Type-2 responses were seen, particularly in ascites and tumor-infiltrating lymphocytes (P values<0.01). With polyclonal stimulation, lymphocytes from all compartments expressed elevated Type-1 cytokines (P values<0.014). Depressed and anxious mood were both associated with significantly lower ratios of polyclonally-stimulated CD4(+) cells producing IFN gamma (TH(1) cells) vs. IL-4 (TH(2) cells) in all compartments (depressed mood: P=0.012; anxiety: P=0.038) and depressed mood was also related to lower ratios of polyclonally-stimulated CD8(+) cells producing IFN gamma (TC(1)) vs. IL-4 (TC(2)) (P=0.035). Although effects of polyclonal stimulation should be generalized with caution to the in vivo immune response, findings suggest that depressed and anxious mood are associated with greater impairment of adaptive immunity in peripheral blood and in the tumor microenvironment among ovarian cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some studies have also reported that MDD may predict lower T-cell cytokine expression and reduce treatment adherence or initiation87,88, while improvement in depressive symptoms has been associated with increased survival in people with cancer89.”
From Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management (2023) · cites this paper as [87]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Some studies have also reported that MDD may predict lower T-cell cytokine expression and reduce treatment adherence or initiation87,88, while improvement in depressive symptoms has been associated with increased survival in people with cancer89.”
From Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management (2023) · cites this paper as [87]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilevel analysis : an introduction to basic and advanced multilevel modeling
Snijders, T. A. B., & Bosker, R. (1999) · Cited by 6,830
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Psychological stress and the human immune system: a meta-analytic study of 30 Years of inquiry
Segerstrom, S. C., & Miller, G. E. (2004) · Psychological Bulletin · doi:10.1037/0033-2909.130.4.601 · Cited by 3,334
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689
Stress, depression, the immune system, and cancer
Reiche, E. M. V., Nunes, S. O. V., & Morimoto, H. K. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01597-9 · Cited by 1,364
A Shortened Version of the Profile of Mood States
Shacham, S. (1983) · Journal of Personality Assessment · doi:10.1207/s15327752jpa4703_14 · Cited by 1,231 · cited 1×
“Mood was assessed using the Profile of Mood States Short Form (POMS-SF) (Curran et al., 1995; Sacham, 1983).”
Maier, S. F., & Watkins, L. R. (1998) · Psychological Review · doi:10.1037/0033-295x.105.1.83 · Cited by 1,130
Short Form of the Profile of Mood States (POMS-SF): Psychometric information.
Curran, S. L., Andrykowski, M. A., & Studts, J. L. (1995) · Psychological Assessment · doi:10.1037//1040-3590.7.1.80 · Cited by 808
Stress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to Disease
Elenkov, I. J., & Chrousos, G. P. (1999) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(99)00188-5 · Cited by 805
Depressive disorders and immunity: 20 years of progress and discovery
Irwin, M. R., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.01.010 · Cited by 676
Cited by
Sorted by citations
Immune system to brain signaling: Neuropsychopharmacological implications
Capuron, L., & Miller, A. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.014 · Cited by 1,195
“Significant associations between markers of inflammation and individual neuropsychiatric symptoms including fatigue and cognitive dysfunction have also been described (Musselman et al., 2001; Meyers et al., 2005; Jehn et al., 2006; Lutgendorf et al., 2008; Bower et al., 2009).”
BackgroundHandbook of Religion and Health
Koenig, H. G., VanderWeele, T. J., & Peteet, J. R. (2023) · doi:10.1093/oso/9780190088859.001.0001 · Cited by 1,160
Impact of Stress on Cancer Metastasis
Moreno‐Smith, M., Lutgendorf, S. K., & Sood, A. K. (2010) · Future Oncology · doi:10.2217/fon.10.142 · Cited by 522
Self-citationDepression in cancer patients: Pathogenesis, implications and treatment (Review)
Smith, H. R. (2015) · Oncology Letters · doi:10.3892/ol.2015.2944 · Cited by 526
“In ovarian cancer patients, depressed and anxious moods were associated with significantly impaired T helper 1 cell levels, cytotoxic T lymphocyte levels and interferon ‑ γ (INF ‑ γ ) secretion in both the microenvironment of the tumour and peripheral blood (48).”
Giese-Davis, J., Collie, K., Rancourt, K. M. S., Neri, E., Kraemer, H. C., & Spiegel, D. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.4455 · Cited by 458
Metadata
- Authors
- Lutgendorf, S. K., Lamkin, D. M., DeGeest, K., Anderson, B., Dao, M., McGinn, S., Zimmerman, B., Maiseri, H., Sood, A. K., & Lubaroff, D. M.
- Affiliations
- University of Iowa (US)
- The University of Texas Medical Branch at Galveston (US)
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Lutgendorf, Susan K.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 22
- Issue
- 6
- Pages
- 890-900
- ISSN
- 0889-1591 (ISSN-L)
- PMC
- PMC2605940
- OpenAlex
- W2095272581
- Cited by
- 126
- References
- 68
- Citations by year
- 2026: 6 · 2025: 3 · 2023: 49 · 2022: 7 · 2021: 4 · 2020: 3 · 2019: 6 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 5 · 2014: 5 · 2013: 7 · 2012: 13
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Brain Behavior and Immunity (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R21CA088293, R21 CA 88293, R01CA104825)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- ovarian cancer, depressive mood, anxiety, T cell cytokines, interferon-gamma, IL-4, Th1/Th2 balance, tumor-infiltrating lymphocytes, ascites, tumor microenvironment, adaptive immunity, psychosocial factors, CD4+ T cells, CD8+ T cells
- MeSH terms
- Aged, Anxiety, Cells, Cultured, Depression, Female, T-Lymphocytes, Helper-Inducer, Humans, Immunity, Interferon Type I, Lymphocyte Activation, Lymphocytes, Middle Aged, Ovarian Neoplasms, Surveys and Questionnaires, T-Lymphocytes, Cytotoxic, Interleukin-4, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
